| Name | Title | Contact Details |
|---|
EG Capital Group is a New York, NY-based company in the Financial Services sector.
Xnergy is a Los Angeles, CA-based company in the Financial Services sector.
Amundi Pioneer Asset Management (Amundi Pioneer) references the US business of the Amundi group of companies, Europe`s largest asset manager by assets under management and among the top ten global asset managers*. Amundi Pioneer was formed in 2017 as part of the acquisition of Pioneer Investments by Amundi, and includes the operations of Amundi Pioneer Asset Management USA Inc., based in Boston, and Amundi Smith Breeden, based in Durham, NC. Incorporating the expertise of the regional hub in Durham, Boston is one of Amundi`s six main investment hubs. In addition to investment management activities, Amundi Pioneer offers and services a wide array of investment solutions for institutional and private investors globally. Pioneer Investments was founded in 1928 by Philip L. Carret, and has been a leading innovator in global asset management since its inception. Amundi Smith Breeden, founded as Smith Breeden Associates in 1982, is a highly regarded relative value credit investor managing an extensive range of fixed-income strategies tailored to the needs of institutional investors. In aggregate, Amundi Pioneer Asset Management offers a broad range of fixed income, equity and multi-asset investment solutions. A focus on proprietary research, robust risk management, disciplined investment processes, and close client partnerships with clients has made the firms that comprise Amundi Pioneer investment managers of choice among leading institutional and individual investors worldwide. Amundi Pioneer had approximately $85.6 billion in assets under management as of May 31, 2017. *Source IPE “Top 400 asset managers” published in June 2017 and based on AUM as at December 2016.
Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world`s most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies. We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories. Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation. Omega Funds has raised more than $1 billion since its inception in 2004 and is headquartered in Boston, Massachusetts, USA.
McMorgan & Company LLC is a San Francisco, CA-based company in the Financial Services sector.